<DOC>
	<DOCNO>NCT00736424</DOCNO>
	<brief_summary>The purpose study collect subject data evaluate rate sudden unexplained death epilepsy ( SUDEP ) bilateral neurostimulation anterior nucleus thalamus people diagnose refractory epilepsy . The data obtain physician initiated study pool data collect Medtronic-sponsored study assess SUDEP risk .</brief_summary>
	<brief_title>Brain Stimulation Epilepsy Long Term Follow-up</brief_title>
	<detailed_description>Medtronic conduct pivotal clinical trial entitle Stimulation Anterior Nucleus Thalamus Epilepsy ( SANTÉ ) . One requirement SANTÉ study evaluate rate sudden unexplained death epilepsy ( SUDEP ) . Medtronic aware approximately 18 subject various type epilepsy treat neurostimulation anterior nucleus thalamus outside SANTÉ trial five physician-sponsored study . This protocol initially collect information regard physician-sponsored study subject ' status . The goal study pool data SANTÉ data purpose estimate SUDEP rate . This multi-center , retrospective prospective clinical study patient previously implant device provide bilateral neurostimulation anterior nucleus thalamus non-Medtronic-sponsored study .</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<criteria>Have receive bilateral AN stimulation anterior nucleus thalamus ( AN ) epilepsy receive time enrollment For patient therapy active time enrollment , ability patient legal representative understand provide sign consent participate study For patient therapy permanently discontinue died time enrollment , IRB/REB approve waiver allow collection data OR ability patient legal representative understand provide sign consent/medical authorization</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>SUDEP</keyword>
	<keyword>DBS</keyword>
</DOC>